Institutional Barriers to the Successful Implementation of Telemedicine for Type 1 Diabetes Care.

Autor:	Lee JM; Susan B. Meister Child Health Evaluation and Research Center, C.S. Mott Children's Hospital, Ann Arbor, MI., Ospelt E; T1D Exchange, Boston, MA., Noor N; T1D Exchange, Boston, MA., Mungmode A; T1D Exchange, Boston, MA., Ebekozien O; T1D Exchange, Boston, MA.; University of Mississippi School of Population Health, Jackson, MS., Gupta M; Seattle Children's Hospital, University of Washington, Seattle, WA., Malik FS; Seattle Children's Hospital, University of Washington, Seattle, WA., Fogel NR; Ann & Robert Lurie Children's Hospital, Chicago, IL., Accacha S; School of Medicine NYU Long Island, Mineola, NY., Hsieh S; Cook Children's Hospital, Fort Worth, TX., Wilkes M; Icahn School of Medicine at Mt. Sinai, New York, NY., Neyman A; Indiana University School of Medicine, Riley Children's Hospital, Indianapolis, IN., Vendrame F; University of Miami Miller School of Medicine, Miami, FL.
Jazyk:	angličtina
Zdroj:	Clinical diabetes : a publication of the American Diabetes Association [Clin Diabetes] 2024 Winter; Vol. 42 (1), pp. 34-39. Date of Electronic Publication: 2023 Sep 07.
DOI:	10.2337/cd23-0056
Abstrakt:	The aim of this study was to describe rates of telemedicine use 18 months after the start of the coronavirus disease 2019 pandemic and to assess the institutional barriers to its implementation for type 1 diabetes care across centers of the T1D Exchange Quality Improvement Collaborative. Observational electronic health record data capturing telemedicine rates from 15 U.S. centers between September 2020 and September 2021 and a survey of 33 centers capturing telemedicine rates and key components of telemedicine were analyzed. A capacity score was developed and summed to a total capacity score and compared with overall telemedicine rates across centers. Telemedicine visits decreased by 17.4% from September 2020 to September 2021. Generally, it was observed that the lower the average telemedicine capacity score, the lower the rate of telemedicine visits. Despite a decline in the utilization of telemedicine 18 months after the start of the pandemic, visit rates were still 20% higher than in the pre-pandemic period. However, there is a need to improve structural components to ensure telemedicine capacity and robust telemedicine utilization. Competing Interests: J.M.L. is on the GoodRx medical advisory board and is a consultant for Tandem. O.E. is a Health Equity Advisory Board member for Medtronic Diabetes. F.V. is a consultant for Eli Lilly. No other potential conflicts of interest relevant to this article were reported. (© 2024 by the American Diabetes Association.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu